The Enterprise Value as of June 2026 (TTM) for PharmaCyte Biotech, Inc. (PMCB) is -14993946.00

According to PharmaCyte Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -14993946.00. This represents a change of 73.05% compared to the average of -8664307.01 of the last 4 quarters.

PharmaCyte Biotech, Inc. (PMCB) Historical Enterprise Value (quarterly & annually)

How has PMCB Enterprise Value performed in the past?

The mean historical Enterprise Value of PharmaCyte Biotech, Inc. over the last ten years is 18.58M. The current -14993946.00 Enterprise Value has changed -8169.10% with respect to the historical average. Over the past ten years (40 quarters), PMCB's Enterprise Value was at its highest in in the January 2017 quarter at 99.29M. The Enterprise Value was at its lowest in in the October 2023 quarter at -50467789.00.

PharmaCyte Biotech, Inc. (PMCB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PharmaCyte Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PharmaCyte Biotech, Inc. (PMCB) Average Enterprise Value

How has PMCB Enterprise Value performed in the past?

The current Enterprise Value of PharmaCyte Biotech, Inc. (PMCB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PharmaCyte Biotech, Inc. (PMCB) Enterprise Value vs. Peers

How is PMCB’s Enterprise Value compared to its peers?

PharmaCyte Biotech, Inc.’s Enterprise Value is less than Radiopharm Theranostics Limited (12.78M), less than Quoin Pharmaceuticals, Ltd. (5.31M), less than NovaBay Pharmaceuticals, Inc. (9.62M), less than Alaunos Therapeutics, Inc. (5.17M), less than VivoSim Labs, Inc. (-737926.00), less than Impact BioMedical Inc. (7.29M), greater than Pasithea Therapeutics Corp. (-46001320.00), less than Polyrizon Ltd. (11.16M), less than Cyclerion Therapeutics, Inc. (11.25M), less than Brainstorm Cell Therapeutics Inc. (9.75M),

Build a custom stock screener for PharmaCyte Biotech, Inc. (PMCB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaCyte Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PharmaCyte Biotech, Inc. (PMCB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PharmaCyte Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.